Erudio Healtherudio.com
Sponsor
Arcus Biosciences trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Arcus Biosciences yet. Erudio has found public clinician commentary on 7 clinical trials sponsored by Arcus Biosciences, including ARC-7, ARC-20, PEAK-1 and STAR-221. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Arcus Biosciences, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ARC-20 NCT05536141 · Arcus Biosciences, Inc. DeepView → | clear cell renal cell carcinoma and solid tumors | Phase 1 | Deep | View | |||
| PEAK-1 NCT07011719 · Arcus Biosciences, Inc. DeepView → | advanced clear cell renal cell carcinoma | Phase 3 | Deep | View | |||
| STAR-221 NCT05568095 · Arcus Biosciences, Inc. DeepView → | previously untreated advanced upper gastrointestinal tract adenocarcinoma | Phase 3 | Deep | View | |||
| ARC-7 NCT04262856 · Arcus Biosciences, Inc. StandardView → | front-line PD-L1 positive non-small cell lung cancer | Phase 2 | Standard | View | |||
| EDGE-Gastric NCT05329766 · Arcus Biosciences, Inc. StandardView → | advanced gastric, gastroesophageal junction or esophageal cancer | Phase 2 | Standard | View | |||
| ARC-10 NCT04736173 · Arcus Biosciences, Inc. FocusedView → | front-line PD-L1-high locally advanced or metastatic NSCLC | Phase 2 | Focused | View | |||
| PRISM-1 NCT06608927 · Arcus Biosciences, Inc. FocusedView → | treatment-naive metastatic pancreatic ductal adenocarcinoma | Phase 3 | Focused | View | |||